Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.
If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.
* Price is subject to applicable taxes.
Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.
(TheNewswire)
Vancouver, British Columbia, Canada
– TheNewswire - May 11, 2021 — Global Cannabis Applications Corp.
(“GCAC” or the “Company) (CSE:APP) (OTC:FUAPF) (FSE:2FA) (CNSX:APP.CN)
$APP $FUAP a leading
developer of innovative data technologies for the medical cannabis
industry, today announced that CEO Brad Moore will be a featured
panelist and presenter at Prohibition Partners LIVE, a
renowned three-day virtual cannabis conference.
On May 18th at 6:45 AM PT, Moore, a former Fortune 500 executive and a
proven operator of early-stage companies, will present on a
four-person panel at Prohibition Partners LIVE’s day one morning
event, “Is There a Doctor in the House? Patient Access to Medical
Cannabis.” Moore will be joined by Mike Barnes,
Chairman of the Medical Cannabis Clinicians Society, Dr. Rebecca
Moore, a consulting psychiatrist with The Medical Cannabis Clinics,
and Richard Hurley, a reporter for The British Medical Journal. The
four speakers will discuss the challenges surrounding the use of
medical cannabis by patients and physicians across the United Kingdom
and Europe.
“GCAC is thrilled to participate in this year’s Prohibition Partners LIVE conference,” said Moore. “I look forward to discussing the current medical cannabis landscape across the United Kingdom – and, frankly, the rest of the world – and detailing how GCAC uses blockchain and other modern technologies to revolutionize access, efficiency, and most importantly- efficacy.”
Prohibition Partners operates the cannabis industry’s premier conferences with ~ 5,000 former global attendees and more than 500 acclaimed past speakers, such as Carlos Santana, Rock and Roll Hall of Famer and Co-Founder, Mirayo: Crispin Blunt, Member of UK Parliament, Conversative Party; Natalie Papillion, Board of Directors, The Last Prisoner Project; Dr. João Castel-Branco Goulão, National Drug Coordinator, Portugal; Bruce Linton, Founder of Canopy Growth; and Kelis, Grammy-Nominated American Singer and Songwriter and host of Netflix’s "Cooked with Cannabis." This year, Prohibition Partners LIVE is forecast to host approximately 800 attendees virtually worldwide.
GCAC is pleased to offer registrants a 20% discount on tickets for the three-day virtual conference, with the use of discount code GCAC20. To register, please visit: https://www.eventbrite.co.uk/e/prohibition-partners-live-may-18-20-2021-tickets-143105553563?aff=GCACPPL2021. In addition, Brad Moore will participate in Prohibition’s “Bespoke 30-Minute Master Class LIVE Q&A,” hosted by Swapcard – and will be featured on Prohibition’s “Sponsored Blog CEO Interview” on the conference’s website.
About Global Cannabis Applications Corp.
Global Cannabis Applications Corp. is a global leader in
designing, developing, SaaS licensing, and acquiring innovative data
technologies for the medical cannabis industry. The Citizen Green and
Efixii platforms are the world’s first end-to-end — from patient
to regulator — medical cannabis data solutions. They use six core
technologies: mobile applications, artificial intelligence, RegTech,
smart databases, Ethereum blockchain, and GCAC smart rewards. These
technologies transparently disclose cannabis chain-of-custody events,
thereby enabling patients to provide crowd-sourced medical cannabis
efficacy data. Driven by digital and cannabis industry experts, GCAC
is focused on generating revenue from licensing its SaaS technology
and acquiring high quality cannabis datasets that greatly improve
patient outcomes.
For more Company information, please visit www.cannappscorp.com, or review its profiles
on www.sedar.com and on the
Canadian Securities Exchange’s website www.thecse.com.
Press Contact
Phone: +1 (800) 409-5679
Email: [email protected]
Forward-Looking
Information
This news release may include
forward-looking information within the meaning of Canadian securities
legislation, concerning the business of GCAC. Forward-looking
information is based on certain key expectations and assumptions made
by the management of GCAC. Although management of the Company believes
that the expectations and assumptions on which such forward-looking
information is based are reasonable, undue reliance should not be
placed on the forward-looking information because GCAC can give no
assurance that they will prove to be correct. Forward-looking
statements contained in this news release are made as of the date of
this news release. GCAC disclaims any intent or obligation to update
publicly any forward-looking information, whether as a result of new
information, future events or results or otherwise, other than as
required by applicable securities laws.
The Canadian Securities Exchange has not reviewed and does not accept responsibility for the adequacy and accuracy of this information.
Copyright (c) 2021 TheNewswire - All rights reserved.